ArticleJournal of imaging2026
Hybrid MICO-LAC Segmentation with Panoptic Tumor Instance Analysis for Dense Breast Mammograms.
Article in Journal of imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study proposes a clinically driven hybrid segmentation framework for dense breast tissue analysis in mammographic images, addressing persistent challenges associated with intensity inhomogeneity, low-contrast, and complex tumor morphology. The framework integrates Multiplicative Intrinsic Component Optimization (MICO_2D) for bias field correction, followed by a distance-regularized multiphase Vese-Chan level-set model for coarse global tumor segmentation. To achieve precise boundary delineation, a localized refinement stage is employed using Localized Active Contours (LAC) with Local Image Fitting (LIF) energy, supported by Gaussian regularization to ensure smooth and coherent boundaries in regions with ambiguous tissue transitions. Building upon the refined semantic tumor mask, the framework further incorporates a panoptic-style tumor instance segmentation stage, enabling the decomposition of connected tumor regions into distinct anatomical instances, which were evaluated on both MIAS and INBreast mammography datasets to demonstrate generalizability. This extension facilitates detailed structural analysis of tumor multiplicity and spatial organization, enhancing interpretability beyond conventional pixel wise segmentation. Experiments conducted on Cranio-Caudal (CC) and Medio-Lateral Oblique (MLO) mammographic views demonstrate competitive performance relative to baseline U-Net and advanced deep learning fusion architectures, including multi-scale and multi-view networks, while offering improved interpretability and robustness. Quantitative evaluation using overlap-related metrics shows strong spatial agreement between predicted and reference segmentations, with per-image Dice Similarity Coefficient (DSC) and Intersection over Union (IoU) distributions reported to ensure reproducibility. Descriptive per-image analysis, supported by bootstrap-based confidence intervals and paired comparisons, indicates consistent performance improvements across images. Robustness analysis under realistic perturbations, including noise, contrast degradation, blur, and rotation, demonstrates stable performance across varying imaging conditions. Furthermore, feature space visualizations using t-SNE and UMAP reveal clear separability between cancerous and non-cancerous tissue regions, highlighting the discriminative capability of the proposed framework. Overall, the results demonstrate the effectiveness, robustness, and clinical motivation of this hybrid panoptic framework for comprehensive dense breast tumor analysis in mammography, while emphasizing reproducibility and conservative statistical assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.